Market Overview

Aethlon Shares Jump Before '60 Minutes' Report On CTE, Vets

Aethlon Shares Jump Before '60 Minutes' Report On CTE, Vets
Related AEMD
Earnings Scheduled For June 8, 2018
35 Biggest Movers From Yesterday

Aethlon Medical (NASDAQ: AEMD) reportedly plays a part in a “60 Minutes” segment on CTE in combat veterans that’s airing Sunday.

The story says combat veterans exposed to bomb blasts are being diagnosed with CTE much like NFL players with a history of concussions.

Aethlon shares traded up as much as 35 percent in Friday trading. The stock closed Friday at $1.56. 

Seeking Alpha reports that Aethlon is the majority owner of Exosome Sciences, which has found a biomarker, TauSome, that could be used to detect CTE in sufferers who are still living.

CTE, which a study found in 110 of the 111 brains of former NFL players, is diagnosed in 65 percent of combat veterans who were studied, according to CBS Corporation (NYSE: CBS).

Related Link:

7 Stocks To Watch Ahead Of The 60 Minutes DEA-Opioid Exposé

Posted-In: 60 minutes Aethlon Medical CTE Exosome Sciences TauSomeBiotech Media General Best of Benzinga


Related Articles (CBS + AEMD)

View Comments and Join the Discussion!

Earnings Scheduled For January 8, 2018

Benzinga's Insider Buys of the Week: Sprint, Cheniere Energy Partners And More